Oosterom R - Search Results

1

Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2.

Gratama JW, Bruin RJ, Lamers CH, Oosterom R, Braakman E, Stoter G, Bolhuis RL. Gratama JW, et al. Among authors: oosterom r. Clin Exp Immunol. 1993 May;92(2):185-93. doi: 10.1111/j.1365-2249.1993.tb03378.x. Clin Exp Immunol. 1993. PMID: 8485906 Free PMC article. Clinical Trial.

2

Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study.

Goey SH, Eggermont AM, Punt CJ, Slingerland R, Gratama JW, Oosterom R, Oskam R, Bolhuis RL, Stoter G. Goey SH, et al. Among authors: oosterom r. Br J Cancer. 1995 Nov;72(5):1283-8. doi: 10.1038/bjc.1995.501. Br J Cancer. 1995. PMID: 7577483 Free PMC article. Clinical Trial.

3

A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance.

Verweij J, Herweijer H, Oosterom R, van der Burg ME, Planting AS, Seynaeve C, Stoter G, Nooter K. Verweij J, et al. Among authors: oosterom r. Br J Cancer. 1991 Aug;64(2):361-4. doi: 10.1038/bjc.1991.307. Br J Cancer. 1991. PMID: 1892765 Free PMC article. Clinical Trial.

4

Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine.

Pronk LC, Planting AS, Oosterom R, Drogendijk TE, Stoter G, Verweij J. Pronk LC, et al. Among authors: oosterom r. Eur J Cancer. 1994;30A(7):1019-22. doi: 10.1016/0959-8049(94)90135-x. Eur J Cancer. 1994. PMID: 7946566 Clinical Trial.

5

Bioavailability of interleukin-2 after reconstitution with albumin.

Lamers CH, Stoter G, Goey SH, Oosterom R, Bolhuis RL. Lamers CH, et al. Among authors: oosterom r. Lancet. 1992 Jul 25;340(8813):241. doi: 10.1016/0140-6736(92)90507-y. Lancet. 1992. PMID: 1353160 No abstract available.

6

Standardizing human chorionic gonadotropin measurements in serum of testicular cancer patients.

Oosterom R, Stoter G. Oosterom R, et al. Clin Chem. 1992 Apr;38(4):601-2. Clin Chem. 1992. PMID: 1568339 No abstract available.

7

Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer.

Rodenburg CJ, Nooter K, Herweijer H, Seynaeve C, Oosterom R, Stoter G, Verweij J. Rodenburg CJ, et al. Among authors: oosterom r. Ann Oncol. 1991 Apr;2(4):305-6. doi: 10.1093/oxfordjournals.annonc.a057941. Ann Oncol. 1991. PMID: 1868026 Free article. Clinical Trial. No abstract available.

8

Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.

Delwel R, van Buitenen C, Salem M, Oosterom R, Touw I, Löwenberg B. Delwel R, et al. Among authors: oosterom r. Leukemia. 1990 Aug;4(8):557-60. Leukemia. 1990. PMID: 2201834

9

Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practice.

Splinter TA, Carney DN, Teeling M, Peake MD, Kho GS, Oosterom R, Cooper EH. Splinter TA, et al. Among authors: oosterom r. J Cancer Res Clin Oncol. 1989;115(4):400-1. doi: 10.1007/BF00400971. J Cancer Res Clin Oncol. 1989. PMID: 2547802

10

Neuron-specific enolase as a guide to the treatment of small cell lung cancer.

Splinter TA, Cooper EH, Kho GS, Oosterom R, Peake MD. Splinter TA, et al. Among authors: oosterom r. Eur J Cancer Clin Oncol. 1987 Feb;23(2):171-6. doi: 10.1016/0277-5379(87)90011-3. Eur J Cancer Clin Oncol. 1987. PMID: 2832176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters